ESTHER ZIMMERMAN: Open Payments
NPI 1063816403 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 27 payments from 12 companies in 2025. Trend: 2023 $304 · 2024 $337 · 2025 $820
Food & beverage: $720Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $361 |
| Organon LLC | 1 | $126 |
| Galderma Laboratories, L.P. | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Amgen Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Biofrontera Inc. | 2 | $33 |
| GENZYME CORPORATION | 1 | $27 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $24 |
| Incyte Corporation | 1 | $24 |
Products named: TREMFYA, VTAMA, DUPIXENT, NEMLUVIO, COSENTYX, OTEZLA, AMELUZ, OPZELURA.
Industry payments across FL — which companies pay providers there.
